[1] |
SEGALÉS J. Porcine circovirus type 2 (PCV2) infections:Clinical signs, pathology and laboratory diagnosis[J]. Virus Res, 2012, 164(1-2):10-19.
|
[2] |
WANG L, ZHAO D, SUN B, et al. Oral vaccination with the porcine circovirus type 2 (PCV-2) capsid protein expressed by Lactococcus lactis induces a specific immune response against PCV-2 in mice[J]. J Appl Microbiol, 2020, 128(1):74-87.
|
[3] |
万青山. 四川部分地区猪圆环病毒2型流行病学调查研究[D]. 成都:四川农业大学, 2013.WAN Q S. Parts of Sichuan epidemiological investigation of porcine circovirus virus type 2[D]. Chengdu:Sichuan Agricultural University, 2013. (in Chinese)
|
[4] |
TISCHER I, GELDERBLOM H, VETTERMANN W, et al. A very small porcine virus with circular single-stranded DNA[J]. Nature, 1982, 295(5844):64-66.
|
[5] |
ELLIS J. Porcine circovirus:a historical perspective[J]. Veterin Pathol, 2014, 51(2):315-327.
|
[6] |
ZHANG H H, HU W Q, LI J Y, et al. Novel circovirus species identified in farmed pigs designated as Porcine circovirus 4, Hunan province, China[J]. Transbound Emerg Dis, 2020, 67(3):1057-1061.
|
[7] |
KU X, CHEN F, LI P, et al. Identification and genetic characterization of porcine circovirus type 3 in China[J]. Transbound Emerg Dis, 2017, 64(3):703-708.
|
[8] |
WANG F, GUO X, GE X N, et al. Genetic variation analysis of Chinese strains of porcine circovirus type 2[J]. Virus Res, 2009, 145(1):151-156.
|
[9] |
吕其壮, 刘娟, 陈艳, 等. 广西北部湾地区猪圆环病毒2型检测及其ORF2遗传变异分析[J]. 中国动物传染病学报, 2018, 26(4):40-46.LV Q Z, LIU J, CHEN Y, et al. Detection and genetic variation analysis of ORF2 gene of porcine circovirus type 2 in Guangxi Beibu gulf region[J]. Chinese Journal of Animal Infectious Diseases, 2018, 26(4):40-46. (in Chinese)
|
[10] |
ZHAI S L, CHEN S N, XU Z H, et al. Porcine circovirus type 2 in China:an update on and insights to its prevalence and control[J]. Virol J, 2014, 11(1):88.
|
[11] |
LIU Y F, GUO Q H, CHEN L, et al. Induction of mucosal immunity by intranasal immunization with recombinant adenovirus expressing major epitopes of Porcine circovirus-2 capsid protein[J]. Vet Immunol Immunopathol, 2013, 154(1-2):48-53.
|
[12] |
YAN M F, ZHU L Q, YANG Q. Infection of porcine circovirus 2 (PCV2) in intestinal porcine epithelial cell line (IPEC-J2) and interaction between PCV2 and IPEC-J2 microfilaments[J]. Virol J, 2014, 11:193.
|
[13] |
LEBLANC J G, AUBRY C, CORTES-PEREZ N G, et al. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria:an update[J]. FEMS Microbiol Lett, 2013, 344(1):1-9.
|
[14] |
亓秀晔, 刘乃芝, 程福亮, 等. 乳酸菌用作口服疫苗表达载体的应用研究进展[J]. 中国酿造, 2019, 38(6):18-23.QI X Y, LIU N Z, CHENG F L, et al. Advances in the application of lactic acid bacteria as oral vaccine expression vector[J]. China Brewing, 2019, 38(6):18-23. (in Chinese)
|
[15] |
邓治邦, 邓洁汝, 潘荞, 等. 猪圆环病毒感染及动物模型研究进展[J]. 动物医学进展, 2011, 32(8):85-88.DENG Z B, DENG J R, PAN Q, et al. Advance in porcine circovirus infection and it's animal models[J]. Progress in Veterinary Medicine, 2011, 32(8):85-88. (in Chinese)
|
[16] |
刘玄福, 宋涛, 芮萍, 等. 河北北部猪圆环病毒2型流行毒株的遗传变异分析[J]. 中国兽医学报, 2018, 38(11):2039-2043.LIU X F, SONG T, RUI P, et al. Genetic variation analysis of prevalent porcine circovirus type 2 strains in northern Hebei province[J]. Chinese Journal of Veterinary Science, 2018, 38(11):2039-2043. (in Chinese)
|
[17] |
郭春艳. 猪圆环病毒2型ORF2基因的原核表达及其单克隆抗体的制备和鉴定[D]. 哈尔滨:东北农业大学, 2009.GUO C Y. Expression of PCV2-ORF2 in prokaryotic cells and its preparation and identification of monoclonal antibodies against Cap protein of PCV2[D]. Harbin:Northeast Agricultural University, 2009. (in Chinese)
|
[18] |
KANDLER O, STETTER K O, KÖHL R. Lactobacillus reuteri sp. nov., a new species of heterofermentative lactobacilli[J]. Zentralblatt Für Bakteriologie:I. Abt. Originale C:Allgemeine, Angewandte Und Ökologische Mikrobiologie, 1980, 1(3):264-269.
|
[19] |
OH P L, BENSON A K, PETERSON D A, et al. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution[J]. ISME J, 2010, 4(3):377-387.
|
[20] |
MORAN N A, MCCUTCHEON J P, NAKABACHI A. Genomics and evolution of heritable bacterial symbionts[J]. Annu Rev Genet, 2008, 42(1):165-190.
|
[21] |
赵东方. 罗伊氏乳酸杆菌的分离鉴定及其抵抗仔猪感染F4+ETEC效果的分析[D]. 哈尔滨:东北农业大学, 2019.ZHAO D F. Isolation and identification of Lactobacillus reuteri and its effection on F4+ETEC infected piglets[D]. Harbin:Northeast Agricultural University, 2019. (in Chinese)
|
[22] |
欧阳海平, 潘永飞, 宋延华. 猪圆环病毒2型疫苗研究进展[J]. 动物医学进展, 2020, 41(1):98-103.OUYANG H P, PAN Y F, SONG Y H. Progress on porcine circovirus 2 vaccine[J]. Progress in Veterinary Medicine, 2020, 41(1):98-103. (in Chinese)
|
[23] |
LENCER W I, VON ANDRIAN U H. Eliciting mucosal immunity[J]. N Engl J Med, 2011, 365(12):1151-1153.
|
[24] |
KALAMPOKIS I, YOSHIZAKI A, TEDDER T F. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease[J]. Arthritis Res Ther, 2013, 15(Suppl 1):S1.
|
[25] |
LI J, KUZIN I, MOSHKANI S, et al. Expanded CD23+/CD21hi B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy[J]. J Immunol, 2010, 184(11):6142-6150.
|
[26] |
王立波, 吴润生, 闫超, 等. 不同佐剂对猪圆环病毒衣壳蛋白免疫原性的影响[J]. 中国畜牧兽医, 2016, 43(11):3037-3046.WANG L B, WU R S, YAN C, et al. Effects of different adjuvants on the immunogenicity of PCV2-Cap protein[J]. China Animal Husbandry & Veterinary Medicine, 2016, 43(11):3037-3046. (in Chinese)
|
[27] |
FORT M, SIBILA M, PÉREZ-MARTÍN E, et al. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model[J]. Vaccine, 2009, 27(30):4031-4037.
|
[28] |
赵晶. 八种PCV2 VLPs疫苗免疫效果评价比较[D]. 泰安:山东农业大学, 2019.ZHAO J. Evaluation and comparison of immune efficacy of eight PCV2 VLPs vaccines[D]. Taian:Shandong Agricultural University, 2019. (in Chinese)
|
[29] |
姚睿智. O-GlcNAc糖基化修饰对急性冷暴露小鼠和仔猪腓肠肌及肝脏葡萄糖代谢的影响[D]. 大庆:黑龙江八一农垦大学, 2019.YAO R Z. Effects of O-GlcNAcylation modification on glucose metabolism in gastrocnemius and liver of acute cold-exposed mice and piglets[D]. Daqing:Heilongjiang Bayi Agricultural University, 2019. (in Chinese)
|
[30] |
MCGHEE J R, MESTECKY J, DERTZBAUGH M T, et al. The mucosal immune system:from fundamental concepts to vaccine development[J]. Vaccine, 1992, 10(2):75-88.
|
[31] |
刘雨丰. 猪圆环病毒2型Cap蛋白主要抗原表位重组复制缺陷型腺病毒的黏膜免疫效果评价[D]. 郑州:河南农业大学, 2012.LIU Y F. Mucosal immune response induced by recombinant adenoviruses expressing the major epitopes of capsid protein of porcine circovirus type 2[D]. Zhengzhou:Henan Agricultural University, 2012. (in Chinese)
|
[32] |
GERRITSEN J, SMIDT H, RIJKERS G T, et al. Intestinal microbiota in human health and disease:the impact of probiotics[J]. Genes Nutr, 2011, 6(3):209-240.
|
[33] |
JIN J, PARK C, CHO S H, et al. The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals[J]. Biochem Biophys Res Commun, 2018, 496(3):846-851.
|
[34] |
侯成才. 猪圆环病毒2型Cap蛋白基因在毕赤酵母中的表达与复合水佐剂的研制[D]. 南京:南京农业大学, 2014.HOU C C. Expression of porcine circovirus type 2 cap gene in pichia pastoris and development of water solubility adjuvants[D]. Nanjing:Nanjing Agricultural University, 2014. (in Chinese)
|
[35] |
YU C, LI X, LIU J W, et al. Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine[J]. Vaccine, 2016, 34(50):6358-6366.
|